Evaluating the pain threshold of patients with sickle cell disease (SCD) proved to be a useful tool for predicting the severity of SCD-related fatigue. These findings hold the potential to expand ...

The United Kingdom has become the first country to give regulatory approval to a medical treatment involving the revolutionary CRISPR gene editing tool.

Nagpur News: Heena Khan (name changed) is a sickle cell patient with a Unique Disability ID (UDID) issued by the government of India. The UDID clearly mentions th ...

The first gene therapy treatment for sickle cell disease has been approved in the U.K. , a move that could offer relief to thousands of people with the disease.

Long Island man cured of sickle cell anemia, making New York state history 02:11. A patient on Long Island is the first in New York to be cured of sickle cell anemia, doctors say.

FDA approves first CRISPR therapy—here’s how it works against sickle cell The landmark treatment turns on another blood protein that prevents sickling. Beth Mole – Dec 8, 2023 6:27 pm | 75 ...

Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that ...

Sickle cell is rare, and it disproportionately impacts African Americans. About 100,000 people in the US are diagnosed with sickle cell and, of those, 20,000 have what’s considered severe disease.

Gina Kolata has been reporting on sickle cell disease since 2018, documenting patient experiences and the science that may lead to cures. Oct. 30, 2023. Share full article. The Latest.

The FDA approved a new treatment for sickle cell disease. The therapy is first to use the ground-editing tool CRISPR.

“Just having sickle cell anaemia and being transfusion dependent is not enough to get a disability reservation. You need to have a painful crisis due to blood clots in blood vessels at least ...

Sickle cell is rare, and it disproportionately impacts African Americans. About 100,000 people in the US are diagnosed with sickle cell and, of those, 20,000 have what’s considered severe disease.